Latest Form 4 insider transactions

David A Duffield, a 10% owner of Workday, Inc., sold 99,613 shares of common stock on September 23, 2026.

Deepika Pakianathan, a Director of Theravance Biopharma, Inc., reported multiple transactions in common stock on September 23, 2026.

Donal O'Connor, a Director of Theravance Biopharma, Inc., reported multiple transactions in common stock on September 23, 2026.

Marc H Mcconnell, a Director of Capital Bancorp Inc, reported multiple transactions in common stock on September 23, 2026.

Neil J Laird, CFO and Treasurer of Ondas Holdings Inc., sold 4,952 shares of common stock on September 24, 2026 for $7.74 per share.

Fred Faching Chang, a Director and 10% owner of Newegg Commerce, Inc., sold 7,164 shares of common stock on 2026-09-22-05:00.

Dean J Mitchell, a Director of Theravance Biopharma, Inc., reported multiple transactions in common stock on September 23, 2026.

Susannah Gray, a Director of Theravance Biopharma, Inc., reported multiple transactions in common stock on September 23, 2026.

Mark S Demilio, a Director of Rh, sold 1,000 shares of common stock on September 22, 2026 for $132.00 per share.

Alsup Laurie Smaldone, a Director of Theravance Biopharma, Inc., reported multiple transactions in common stock on September 23, 2026.

Rick E Winningham, CHIEF EXECUTIVE OFFICER and a Director of Theravance Biopharma, Inc., reported multiple transactions in common stock on September 23, 2026.

Aziz Sawaf, SVP & CHIEF FINANCIAL OFFICER of Theravance Biopharma, Inc., reported multiple transactions in common stock on September 23, 2026.

Aine Miller, SVP, DEV & HEAD OF IRE OFFICE of Theravance Biopharma, Inc., reported multiple transactions in common stock on September 23, 2026.

Brett A. Grimaud, SVP, GEN COUNSEL AND SECRETARY of Theravance Biopharma, Inc., reported multiple transactions in common stock on September 23, 2026.

Rhonda Farnum, SVP, COMM & MEDICAL AFFAIRS of Theravance Biopharma, Inc., reported multiple transactions in common stock on September 23, 2026.

Susan Butenhoff, a Director of Ooma Inc, sold 9,000 shares of common stock on September 22, 2026 for $22.02 per share.

George Kurtz, PRESIDENT AND CEO and a Director of CrowdStrike Holdings, Inc., sold 20,000 shares of common stock on September 22, 2026.

Yi-Kuei Chen, Chief Operating Officer and a Director of Apollomics Inc., reported multiple transactions in common stock on September 14, 2026.

Peter Kuan-How Lin, Chief Financial Officer of Apollomics Inc., reported multiple transactions in common stock on September 14, 2026.

Hung Hsien Yen, a Director of Apollomics Inc., reported multiple transactions in common stock on September 14, 2026.

Jessica Newcomb, Principal Accounting Officer of Tango Therapeutics, Inc., sold 8,200 shares of common stock on September 22, 2026.

Robert P Rozek, EVP, CFO & CCO of Korn Ferry, sold 3,709 shares of common stock on September 23, 2026 for $75.03 per share.

Simon Baloyi, Chief Executive Officer and a Director of Sasol Ltd, sold 5,041 shares of common stock on September 4, 2026 for $12.70 per share.

Walt Paul Bruns, Chief Financial Officer and a Director of Sasol Ltd, sold 7,890 shares of common stock on September 4, 2026 for $12.70 per share.

Dss, Inc. reported changes in beneficial ownership of Dss, Inc. common stock on September 22, 2026.

Dss, Inc. reported changes in beneficial ownership of Impact Biomedical Inc. common stock on September 22, 2026.

Michael N Intrator, CEO and President, a Director and 10% owner of CoreWeave, Inc., sold 307,692 shares of common stock on September 22, 2026.

Sarushen Dhanapalan Pillay, EVP, Business Building of Sasol Ltd, sold 782 shares of common stock on September 4, 2026 for $12.70 per share.

Nitin Agrawal, Chief Financial Officer of CoreWeave, Inc., sold 55,764 shares of common stock on September 22, 2026.

Kyle Robert Miller, President of United Parks & Resorts Inc., reported multiple transactions in common stock on September 22, 2026.